Premium
Pituitary gigantism treated successfully with the growth hormone receptor antagonist, pegvisomant
Author(s) -
Daniel A.,
d' Emden M.,
Duncan E.
Publication year - 2013
Publication title -
internal medicine journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 1444-0903
DOI - 10.1111/imj.12077
Subject(s) - medicine , pegvisomant , gigantism , growth hormone , acromegaly , hormone
A Caucasian male aged 15 years presented with 2 years\udaccelerated linear growth. He was 202 cm tall at\udpresentation, with calculated mid-parental height of\ud173 cm. There were no features of hypopituitarism or\udacral growth. His visual fields and optic discs were\udnormal..
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom